Web Results

Astellas Pharma - Wikipedia


Astellas Pharma Inc is a Japanese pharmaceutical company, formed on 1 April 2005 from the ... Fujisawa acquired Lyphomed in 1990 and thereafter established its US R&D center in Deerfield, Illino...

Astellas Pharma US, Inc. | Home


A Astellas Pharma US, Inc. is committed to providing patients, customers, community and employees with a bright future by changing tomorrow. Our commitment ...

Astellas Pharma US, Inc. | North American Locations


North American Locations. Astellas US LLC Headquarters for the Americas Northbrook, Illinois 1-800-888-7704. Astellas Pharma US, Inc. Sales & Marketing

Astellas Pharma US, Inc. Company Information | Drugs.com


Astellas Pharma US, Inc. manufactures, markets and/or distributes more than 11 drugs in the U.S..

Astellas Pharma | LinkedIn


Astellas Pharma US, Inc., a U.S. affiliate of Tokyo-based Astellas Pharma Inc., is a pharmaceutical company dedicated to changing tomorrow by improving the ...

Astellas Pharma US | LinkedIn


Astellas Pharma US, Inc. is a U.S. affiliate of Tokyo-based Astellas Pharma Inc. Located in Northbrook, Illinois, the company serves as the headquarters for the ...

Astellas Pharma US Employee Reviews | Glassdoor


Jan 8, 2017 ... 114 Astellas Pharma US reviews. A free inside look at ... Approves of CEO. I have been working at Astellas Pharma US full-time (More than a year). Pros ..... Glassdoor. Glassdoor ® is a registered trademark of Glassdoor, Inc.

Astellas Pharma Us, Inc.|Company Profile|Vault.com


Find out more about Astellas Pharma Us, Inc. including an overview, stats, history and other Pharmaceuticals and Biotechnology competitors.

Astellas Pharma US (@AstellasUS) | Twitter


The latest Tweets from Astellas Pharma US (@AstellasUS). A pharma company dedicated to changing tomorrow by improving the health of people around the ...

Astellas Announces Transfer of U.S. Manufacturing Subsidiary to ...


Aug 3, 2016 ... TOKYO, Aug. 4, 2016 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, "Astellas") today announced ...